Corvex, Inc. (NASDAQ: MOVE)

Corvex, Inc. operates at the intersection of artificial intelligence infrastructure and digital health, delivering GPU-accelerated cloud computing solutions alongside wearable health technology. The company was formed through a merger completed in March 2026, consolidating expertise in high-performance AI workloads and women-centric health monitoring devices. Corvex’s dual focus positions it within the rapidly expanding AI cloud services market and the growing wearable medical device sector, targeting enterprises and consumers alike.

Corvex generates revenue primarily through long-term contracts for its AI cloud computing services, which provide GPU-accelerated infrastructure for training and deploying artificial intelligence models. Customers commit to annual or multi-year reservations, paying for secure, scalable compute resources tailored to AI workloads. In its healthcare division, the company previously earned sales from the Wellness Ring, a consumer wearable, though commercial operations have been paused. Future revenue may also stem from its FDA-cleared Medical Ring, which is positioned for prescription-based sales in clinical and remote patient monitoring applications.

The company operates through the following segments:

• AI Cloud Computing: This segment delivers GPU-accelerated infrastructure designed for AI model training and inference. It offers AI factories and GPU clusters, confidential computing for secure workloads, and a forthcoming Token Factory platform for optimized AI model access. The infrastructure supports bare metal and Kubernetes deployments, with compliance certifications including HIPAA and SOC 2. Corvex provides hands-on support, consulting, and workload optimization to enterprise customers requiring high-performance, low-latency compute environments.

• Healthcare: This segment focuses on wearable health technology, including the Wellness Ring and the FDA-cleared Medical Ring. The Wellness Ring tracks metrics such as heart rate, blood oxygen, sleep, and menstrual health, targeting women’s wellness. The Medical Ring, cleared for pulse oximetry, is intended for clinical applications, including remote patient monitoring and clinical trials. The division also develops proprietary System-on-a-Chip technology for future blood pressure and continuous glucose monitoring devices.

Corvex competes in a highly dynamic and capital-intensive industry dominated by hyperscale cloud providers and specialized AI infrastructure firms. Key competitors include Amazon Web Services, Google Cloud Platform, Microsoft Azure, CoreWeave, and Nebius Group. Unlike general-purpose cloud platforms, Corvex differentiates itself through purpose-built AI infrastructure optimized for high-density GPU workloads, offering predictable performance, enhanced security, and cost efficiency. Its confidential computing capabilities and compliance certifications further strengthen its appeal to security-conscious enterprises, particularly in healthcare, finance, and government sectors. In the wearable health market, Corvex stands out with its FDA-cleared Medical Ring, which offers clinical-grade accuracy across both hardware and software, a rarity among consumer wearables.

Corvex serves a diverse customer base spanning technology companies, healthcare organizations, financial institutions, and government agencies. Its AI cloud computing segment primarily targets enterprises requiring mission-critical AI workloads, such as training large language models and real-time analytics. While specific customer names are not disclosed, the company’s platform supports industries with stringent performance, security, and compliance requirements. In healthcare, the Wellness Ring was sold directly to consumers in the United States, while the Medical Ring is positioned for prescription-based distribution to clinicians, clinical trial sponsors, and payors.